Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2000 2
2001 1
2002 2
2003 4
2004 4
2005 8
2006 7
2007 7
2008 14
2009 16
2010 8
2011 11
2012 12
2013 15
2014 16
2015 13
2016 4
2017 12
2018 19
2019 22
2020 31
2021 35
2022 34
2023 45
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

295 results

Results by year

Filters applied: . Clear all
Page 1
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.
Elad S, Cheng KKF, Lalla RV, Yarom N, Hong C, Logan RM, Bowen J, Gibson R, Saunders DP, Zadik Y, Ariyawardana A, Correa ME, Ranna V, Bossi P; Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO). Elad S, et al. Cancer. 2020 Oct 1;126(19):4423-4431. doi: 10.1002/cncr.33100. Epub 2020 Jul 28. Cancer. 2020. PMID: 32786044 Free PMC article.
Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer.
Maertens J, Lodewyck T, Donnelly JP, Chantepie S, Robin C, Blijlevens N, Turlure P, Selleslag D, Baron F, Aoun M, Heinz WJ, Bertz H, Ráčil Z, Vandercam B, Drgona L, Coiteux V, Llorente CC, Schaefer-Prokop C, Paesmans M, Ameye L, Meert L, Cheung KJ, Hepler DA, Loeffler J, Barnes R, Marchetti O, Verweij P, Lamoth F, Bochud PY, Schwarzinger M, Cordonnier C; Infectious Diseases Group and the Acute Leukemia Group of the European Organization for Research and Treatment of Cancer. Maertens J, et al. Among authors: blijlevens n. Clin Infect Dis. 2023 Feb 18;76(4):674-682. doi: 10.1093/cid/ciac623. Clin Infect Dis. 2023. PMID: 35906831 Free PMC article. Clinical Trial.
Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: a multicentre, prospective, cluster randomised, crossover clinical trial.
Veringa A, Brüggemann RJ, Span LFR, Biemond BJ, de Boer MGJ, van den Heuvel ER, Klein SK, Kraemer D, Minnema MC, Prakken NHJ, Rijnders BJA, Swen JJ, Verweij PE, Wondergem MJ, Ypma PF, Blijlevens N, Kosterink JGW, van der Werf TS, Alffenaar JC; Voriconazole ZonMw Study Group. Veringa A, et al. Among authors: blijlevens n. Int J Antimicrob Agents. 2023 Feb;61(2):106711. doi: 10.1016/j.ijantimicag.2023.106711. Epub 2023 Jan 13. Int J Antimicrob Agents. 2023. PMID: 36642232 Free article. Clinical Trial.
10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial.
Lübbert M, Wijermans PW, Kicinski M, Chantepie S, Van der Velden WJFM, Noppeney R, Griškevičius L, Neubauer A, Crysandt M, Vrhovac R, Luppi M, Fuhrmann S, Audisio E, Candoni A, Legrand O, Foà R, Gaidano G, van Lammeren-Venema D, Posthuma EFM, Hoogendoorn M, Giraut A, Stevens-Kroef M, Jansen JH, de Graaf AO, Efficace F, Ammatuna E, Vilque JP, Wäsch R, Becker H, Blijlevens N, Dührsen U, Baron F, Suciu S, Amadori S, Venditti A, Huls G; EORTC Leukemia Group, GIMEMA, and German MDS Study Group. Lübbert M, et al. Among authors: blijlevens n. Lancet Haematol. 2023 Nov;10(11):e879-e889. doi: 10.1016/S2352-3026(23)00273-9. Lancet Haematol. 2023. PMID: 37914482 Free article. Clinical Trial.
Biomarkers and non-invasive tests for gastrointestinal mucositis.
Kuiken NSS, Rings EHHM, Blijlevens NMA, Tissing WJE. Kuiken NSS, et al. Among authors: blijlevens nma. Support Care Cancer. 2017 Sep;25(9):2933-2941. doi: 10.1007/s00520-017-3752-2. Epub 2017 May 24. Support Care Cancer. 2017. PMID: 28536886 Free PMC article. Review.
Infections in patients with hematological cancer: recent developments.
O'Brien SN, Blijlevens NM, Mahfouz TH, Anaissie EJ. O'Brien SN, et al. Among authors: blijlevens nm. Hematology Am Soc Hematol Educ Program. 2003:438-72. doi: 10.1182/asheducation-2003.1.438. Hematology Am Soc Hematol Educ Program. 2003. PMID: 14633794 Review.
Mucositis and Infection in Hematology Patients.
Blijlevens NMA, de Mooij CEM. Blijlevens NMA, et al. Int J Mol Sci. 2023 May 31;24(11):9592. doi: 10.3390/ijms24119592. Int J Mol Sci. 2023. PMID: 37298545 Free PMC article.
Filling the gaps of patient information and comprehension.
Ector GICG, Hermens RPMG, Blijlevens NMA. Ector GICG, et al. Among authors: blijlevens nma. Curr Opin Oncol. 2020 Jul;32(4):262-268. doi: 10.1097/CCO.0000000000000633. Curr Opin Oncol. 2020. PMID: 32541311 Review.
Emerging evidence on the pathobiology of mucositis.
Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, Logan RM, Nair RG, Stringer AM, Yazbeck R, Elad S, Lalla RV; Mucositis Study Group of Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Al-Dasooqi N, et al. Among authors: blijlevens n. Support Care Cancer. 2013 Jul;21(7):2075-83. doi: 10.1007/s00520-013-1810-y. Epub 2013 Apr 21. Support Care Cancer. 2013. PMID: 23604521 Review.
295 results